A newly published manuscript authored by Dr. Gunda Georg, YourChoice Therapeutics and Columbia University Medical Center ...
John Kempen, MD, MPH, PhD, MHS, Director of Epidemiology for Ophthalmology at Mass Eye and Ear and Harvard Medical School, is ...
Self-administered injectable contraceptives, which are progestin-only shots taken at home every three months, have been ...
Trachoma is the leading cause of infectious blindness in the world, with Ethiopia the most impacted country in Africa. In a ...
First MIRACLE trial unblinding expected Q1 2026; Global trial now spans nine countries– Investigator-Initiated (IIT) funded pancreatic and ...
In a small pilot study of patients with advanced pancreatic cancer, early access to medical cannabis shows promise in the ...
Adding yoga to standard treatment for opioid use disorder is associated with faster recovery from opioid withdrawal symptoms.
Under Robert F. Kennedy Jr.’s guidance, the CDC no longer recommends routine vaccination to protect against meningococcal ...
ORKA-002 interim Phase 1 data demonstrates a half-life of 75-80 days supporting potential for twice-per-year dosing in psoriasis and quarterly ...
New peer-reviewed research adds to substantial body of scientific evidence highlighting the safety of natural kratom leaf ...
Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...